Nivasorexant (INN; developmental code name ACT-539313) is an orexin receptor antagonist which is under development for the treatment of binge eating disorder and was previously under development for the treatment of anxiety disorders.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.